Literature DB >> 32442023

Cardiovascular Toxicities Associated with Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.

Lee S Nguyen1, Charles Dolladille2, Milou-Daniel Drici3, Charlotte Fenioux4, Joachim Alexandre2, Jean-Paul Mira5, Javid J Moslehi6, Dan M Roden7, Christian Funck-Brentano4, Joe-Elie Salem8.   

Abstract

Entities:  

Year:  2020        PMID: 32442023     DOI: 10.1161/CIRCULATIONAHA.120.048238

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  29 in total

Review 1.  Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths.

Authors:  Shivraj Padiyar; Debashish Danda
Journal:  Eur J Rheumatol       Date:  2020-10-08

2.  Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.

Authors:  Anis Saib; Walid Amara; Pascal Wang; Simon Cattan; Azeddine Dellal; Kais Regaieg; Stephane Nahon; Olivier Nallet; Lee S Nguyen
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

3.  Drugs in COVID-19 Clinical Trials: Predicting Transporter-Mediated Drug-Drug Interactions Using In Vitro Assays and Real-World Data.

Authors:  Sook Wah Yee; Bianca Vora; Tomiko Oskotsky; Ling Zou; Sebastian Jakobsen; Osatohanmwen J Enogieru; Megan L Koleske; Idit Kosti; Mattias Rödin; Marina Sirota; Kathleen M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2021-05-03       Impact factor: 6.875

4.  Open science saves lives: lessons from the COVID-19 pandemic.

Authors:  Lonni Besançon; Nathan Peiffer-Smadja; Corentin Segalas; Haiting Jiang; Paola Masuzzo; Cooper Smout; Eric Billy; Maxime Deforet; Clémence Leyrat
Journal:  BMC Med Res Methodol       Date:  2021-06-05       Impact factor: 4.615

Review 5.  Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials.

Authors:  Ahmed M Kamel; Mona S A Monem; Nour A Sharaf; Nada Magdy; Samar F Farid
Journal:  Rev Med Virol       Date:  2021-06-02       Impact factor: 11.043

6.  Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.

Authors:  Bhagteshwar Singh; Hannah Ryan; Tamara Kredo; Marty Chaplin; Tom Fletcher
Journal:  Cochrane Database Syst Rev       Date:  2021-02-12

7.  Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis.

Authors:  Marie Lecronier; Alexandra Beurton; Sonia Burrel; Luc Haudebourg; Robin Deleris; Julien Le Marec; Sara Virolle; Safaa Nemlaghi; Côme Bureau; Pierre Mora; Martin De Sarcus; Olivier Clovet; Baptiste Duceau; Paul Henri Grisot; Marie Hélène Pari; Jérémy Arzoine; Ulrich Clarac; David Boutolleau; Mathieu Raux; Julie Delemazure; Morgane Faure; Maxens Decavele; Elise Morawiec; Julien Mayaux; Alexandre Demoule; Martin Dres
Journal:  Crit Care       Date:  2020-07-11       Impact factor: 9.097

8.  Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19.

Authors:  Christian Funck-Brentano; Lee S Nguyen; Joe-Elie Salem
Journal:  Lancet       Date:  2020-07-09       Impact factor: 79.321

9.  Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19.

Authors:  Yannick Binois; Hafsah Hachad; Joe-Elie Salem; Julien Charpentier; Bénédicte Lebrun-Vignes; Frédéric Pène; Alain Cariou; Jean-Daniel Chiche; Jean-Paul Mira; Lee S Nguyen
Journal:  Kidney Int Rep       Date:  2020-08-06

10.  In silico investigation of pro-arrhythmic effects of azithromycin on the human ventricle.

Authors:  Yizhou Liu; Rai Zhang; Jules C Hancox; Henggui Zhang
Journal:  Biochem Biophys Rep       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.